LDL Cholesterol (LDL-C): Normal Range, Levels Chart, and What Your Number Means

QUICK ANSWER

LDL-C (low-density lipoprotein cholesterol) is the primary measure of "bad" cholesterol — the particles responsible for depositing cholesterol into artery walls, leading to plaque buildup and cardiovascular disease.

LDL cholesterol levels — what your number means:

If you have a specific number — what it typically means:

Your LDL target depends on your overall cardiovascular risk — not just the number itself. A result of 130 mg/dL may be acceptable for a healthy 30-year-old but unacceptably high for someone who has had a heart attack.

Key takeaway: LDL-C is one piece of the cardiovascular risk picture. Interpreting it alongside HDL, triglycerides, total cholesterol, and personal risk factors gives the most complete assessment.

WHAT IS LDL-C AND HOW IS IT MEASURED?

LDL (low-density lipoprotein) particles transport cholesterol from the liver to cells throughout the body. When LDL levels are elevated, excess cholesterol can deposit in artery walls, triggering inflammation and plaque formation — the process known as atherosclerosis.

Calculated LDL vs direct LDL:

Most lab reports show a calculated LDL result, not a direct measurement. The standard method is the Friedewald equation:

LDL = Total Cholesterol − HDL − (Triglycerides ÷ 5)

This calculation is accurate when triglycerides are below 400 mg/dL. When triglycerides are very high (above 400 mg/dL), the Friedewald equation becomes unreliable and a direct LDL measurement is needed.

On your lab report, you may see:

• "LDL-C Calc" or "LDL Chol Calc (NIH)" = calculated using Friedewald
• "LDL-C NIH Calc" = same calculation, NIH-validated formula
• "LDL DIRECT" or "LIPOPROT.(LDL) DIRECT" = directly measured LDL

Both calculated and direct LDL use the same reference ranges.

Unit conversion: mg/dL × 0.0259 = mmol/L. For example, 100 mg/dL = 2.59 mmol/L.

WHAT DOES HIGH LDL MEAN?

High LDL-C means more LDL particles are circulating in the blood, increasing the risk of cholesterol depositing in artery walls. It does not cause symptoms — elevated LDL is detected only through a blood test.

Causes of high LDL:

Diet and lifestyle

• Saturated fat and trans fat intake — the most modifiable cause; saturated fats (red meat, full-fat dairy, tropical oils) stimulate the liver to produce more LDL; trans fats (partially hydrogenated oils) both raise LDL and lower HDL
• Low physical activity — exercise raises HDL and modestly lowers LDL
• Obesity — excess body fat, particularly visceral fat, increases LDL and triglycerides
• Smoking — lowers HDL and promotes LDL oxidation, accelerating atherosclerosis

Medical conditions

• Hypothyroidism — thyroid hormone regulates LDL receptor activity; low thyroid → reduced LDL clearance → elevated LDL
• Nephrotic syndrome — protein loss in urine triggers compensatory hepatic lipoprotein overproduction
• Obstructive liver disease — impairs normal lipoprotein metabolism
• Type 2 diabetes / insulin resistance — associated with small, dense LDL particles that are more atherogenic
• Polycystic ovary syndrome (PCOS)

Genetic causes

• Familial hypercholesterolemia (FH) — the most important genetic cause; LDL receptors are defective or absent, preventing LDL clearance. LDL typically > 190 mg/dL in heterozygous FH, > 400 mg/dL in homozygous FH. Affects 1 in 250 people — most go undiagnosed.
• Polygenic hypercholesterolemia — multiple common genetic variants each contribute modestly to elevated LDL

Medications

• Corticosteroids (prednisone), progestins, anabolic steroids, some retinoids, thiazide diuretics, and beta-blockers can raise LDL

WHAT DOES LOW LDL MEAN?

Very low LDL (under 40 mg/dL) is uncommon and generally not a primary health concern in most people. In patients on high-intensity statin therapy, LDL levels below 50 mg/dL are deliberately achieved to reduce cardiovascular events — this is safe and beneficial.

Causes of genuinely low LDL (not medication-induced):

• Hyperthyroidism — elevated thyroid hormone increases LDL receptor activity and LDL clearance
• Severe malnutrition or malabsorption syndromes
• Abetalipoproteinemia (rare genetic disorder — inability to produce LDL-containing lipoproteins)
• Severe liver disease — reduced lipoprotein synthesis
• Chronic infection or inflammatory states — acute-phase response temporarily lowers lipids

A very low LDL not explained by statin use warrants evaluation for the above conditions.

LDL CHOLESTEROL — RISK PROGRESSION BY LEVEL

LDL-C does not flip from "safe" to "dangerous" at a single threshold — risk increases progressively as LDL rises:

Each 38.6 mg/dL (1 mmol/L) reduction in LDL-C is associated with approximately a 22% reduction in major cardiovascular events over 5 years, based on statin trial data — making LDL reduction one of the most evidence-supported interventions in preventive medicine.

LDL RISK CATEGORIES AND TREATMENT TARGETS

LDL target levels are not one-size-fits-all — they depend on overall cardiovascular risk:

Based on 2018 ACC/AHA Guideline on the Management of Blood Cholesterol.

Familial hypercholesterolemia: LDL ≥ 190 mg/dL without a clear secondary cause warrants evaluation for FH regardless of other risk factors. FH requires statin therapy regardless of calculated ASCVD risk.

HOW LDL RELATES TO HDL, TRIGLYCERIDES, AND TOTAL CHOLESTEROL

LDL-C should be interpreted as part of the full lipid panel:

Non-HDL cholesterol (Total Cholesterol − HDL) is increasingly used alongside LDL-C because it captures all atherogenic particles, including VLDL and IDL. Non-HDL target is typically 30 mg/dL higher than the LDL target for the same risk category.

High LDL + high triglycerides + low HDL is the classic metabolic syndrome lipid pattern and carries higher cardiovascular risk than elevated LDL in isolation.

LDL-C VS APOB VS LDL PARTICLE NUMBER

Standard lipid panels measure LDL-C — the cholesterol content inside LDL particles. But two people with the same LDL-C can have very different cardiovascular risk depending on the number of LDL particles carrying that cholesterol.

When LDL-C and ApoB disagree (discordance):

• High ApoB with normal LDL-C = more particles carrying less cholesterol each — higher risk than LDL-C suggests. Common in metabolic syndrome, insulin resistance, and elevated triglycerides.
• Normal ApoB with elevated LDL-C = fewer, larger LDL particles carrying more cholesterol each — lower risk than LDL-C suggests. More common in people with high HDL.

ApoB is now recommended alongside LDL-C by some major guidelines (European Society of Cardiology 2019, Canadian Cardiovascular Society) for patients whose LDL-C may underestimate risk — particularly those with metabolic syndrome, diabetes, or low HDL. ApoB target for high-risk patients: under 70 mg/dL; very high risk: under 65 mg/dL.

WHY IS MY LDL HIGH BUT TRIGLYCERIDES ARE NORMAL?

This is one of the most common combinations on a lipid panel — and one of the most frequently misunderstood. High LDL with normal triglycerides (under 150 mg/dL) points strongly toward genetic or dietary causes rather than metabolic syndrome.

When triglycerides are high alongside LDL, that typically signals insulin resistance, obesity, or poor diet broadly. When LDL is elevated in isolation with normal triglycerides and normal HDL, the differential is narrower:

1. Genetics — the most important cause to consider. Familial hypercholesterolemia (LDL ≥ 190 mg/dL), polygenic hypercholesterolemia, or familial combined hyperlipidemia all elevate LDL preferentially without necessarily raising triglycerides. If LDL has been persistently elevated since a young age, or a first-degree relative had early heart disease or very high cholesterol, genetic cause is likely.
2. Diet high in saturated fat. Saturated fat raises LDL primarily by reducing hepatic LDL receptor activity — it does not necessarily raise triglycerides, especially if total caloric intake and carbohydrate intake are not excessive.
3. Hypothyroidism. Low thyroid hormone reduces LDL receptor expression, causing LDL accumulation. Triglycerides may be mildly elevated or normal. A TSH test alongside the lipid panel can identify this.
4. Medications. Corticosteroids, some beta-blockers, and progestins raise LDL without a proportional effect on triglycerides.

What to check next: If LDL is consistently above 160 mg/dL with normal triglycerides and no clear dietary explanation, TSH (thyroid function) and a family history review are the priority next steps. LDL ≥ 190 mg/dL warrants formal familial hypercholesterolemia evaluation.

WHEN TO FOLLOW UP

Discuss your LDL result with a clinician if:

• LDL is ≥ 190 mg/dL without a clear dietary or medication cause — familial hypercholesterolemia evaluation is warranted
• LDL is above your risk-based target (e.g., above 70 mg/dL with prior heart attack, above 100 mg/dL with diabetes)
• LDL has risen significantly from a previous result without obvious explanation
• You are on statin therapy and LDL has not reached target after 8–12 weeks
• LDL is very low (under 40 mg/dL) without statin use

INTERNAL LINKS

Related lipid panel markers: HDL Cholesterol · Total Cholesterol · Triglycerides · Non-HDL Cholesterol · VLDL Cholesterol

BOTTOM LINE

Bottom line: LDL-C is the primary cardiovascular risk marker in a lipid panel. The number alone is not sufficient — your LDL target depends on your overall risk profile. Under 100 mg/dL is the general optimal target; under 70 mg/dL is required for patients with established cardiovascular disease. LDL ≥ 190 mg/dL without explanation warrants evaluation for familial hypercholesterolemia. Always interpret LDL alongside HDL, triglycerides, and total cholesterol.